At the University Hospital of Basel (USB), a promising neuroplastic therapeutic approach is being tested as part of the fatigue clinic. Based on the fundamental assumption that while fatigue and other long-COVID symptoms are real, they should be interpreted as neuroplastically stabilized protective mechanisms of the brain that have developed through learning processes, neuroplasticity offers the opportunity to reprogram dysfunctional patterns through targeted interventions.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Casuistry
Chronic eosinophilic pneumonia in RA
- Case Study: Secondary Pseudohypoaldosteronism
Severe electrolyte imbalances and nonspecific symptoms in an infant
- CKD and High Blood Pressure
Keeping an Eye on Bidirectional Interactions
- Molecular Classification, FIGO 2023, and Chemoimmunotherapy
Endometrial carcinoma
- Psoriatic Arthritis
Older patients at risk for tachyarrhythmias
- Genetic Kidney Disease: DOUBLE PROTECT Alport
The SGLT-2 inhibitor dapagliflozin as an add-on to RAS blockade
- Case Study: Cystic Fibrosis in Adults
Recurrent Pneumonia as a Manifestation of Cystic Fibrosis
- Long COVID/Fatigue Clinic